Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Ramsay Health Care ( (AU:RHC) ) is now available.
Ramsay Health Care announced two significant non-recurring financial impacts for the six months ending December 2024: a $291 million impairment in its UK segment due to challenges in its Elysium mental health services, and the release of a $64.5 million tax provision related to its Ramsay Santé acquisition. The company is taking steps to improve Elysium’s operational rigour, including appointing a new COO and halting site expansion, while focusing on its core UK hospital business, which is showing strengthened performance. Despite these efforts, Ramsay does not expect growth in NPAT for FY25 due to the impairment.
More about Ramsay Health Care
Ramsay Health Care is a global healthcare provider, operating hospitals and mental health services. Its market focus includes partnering with the NHS in the UK to reduce elective surgery waitlists, and it offers a variety of healthcare services across its facilities.
YTD Price Performance: 1.16%
Average Trading Volume: 1,090
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.8B
For a thorough assessment of RHC stock, go to TipRanks’ Stock Analysis page.
